Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag Concentrations in Breast Milk
NCT01055600Phase 4Withdrawn
- Sponsor
- GSK
- Start
- Mar 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eltrombopag in Thrombocytopenia, sponsored by GSK. Planned start Mar 2013; status: withdrawn.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01055600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01055600.